Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Interest Expenses (2024 - 2025)

Incannex Healthcare (IXHL) has disclosed Interest Expenses for 2 consecutive years, with -$5000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 82.14% to -$5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122000.0 through Dec 2025, up 317.86% year-over-year, with the annual reading at $303000.0 for FY2025, N/A changed from the prior year.
  • Interest Expenses hit -$5000.0 in Q4 2025 for Incannex Healthcare, roughly flat from -$5000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $132000.0 in Q1 2025 to a low of -$28000.0 in Q3 2024.